Acetylon Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
6 employees
- Employees
- 6
Acetylon Pharmaceuticals, Inc. Overview
- Phone Number
- Available in AeroLeads
- Website
- acetylon.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 6
- Funding
- 100.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme inhibitors with potential for treatment of hematologic and solid tumor cancers, inflammatory diseases such as rheumatoid arthritis, neurodegenerative diseases such as Parkinson's, genetic diseases incluidng sickle cell disease and thalassemia major, and infectious disease such as malaria. Acetylon's technology is being licensed from Harvard University and the Dana Farber Cancer Center. Acetylon raised $7.25M in a Series A finanicng involving private investors including The Kraft Group in July 2009.
Acetylon Pharmaceuticals, Inc. Contact Details
Compare Similar Companies to Acetylon Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Biotechnology Research
TSUMURA & CO.
Pharmaceutical Manufacturing
Advanced Pharma - Miami
Research Services
AFFYMAX Research Institute
Biotechnology Research
Vitae Pharmaceuticals
Pharmaceutical Manufacturing
Polaryx Therapeutics
Biotechnology Research
Regenacy Pharmaceuticals, Inc.
Biotechnology
Tolero Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Actimis Pharmaceuticals
Pharmaceutical Manufacturing
Antagen Pharmaceuticals, COVID-19 Testing Products
Pharmaceutical Manufacturing